Efficacy and Tolerability of the APD Treatment in PAED Patients

Inclusion Criteria: * Informed consent signed and dated by legal representative and investigator/authorized physician * The minors have received the information referred to in Article 63(2) MDR in a way adapted to their age and mental maturity and from investigators or members of the investigating team who are trained or experienced in working with children * The explicit wish of a minor who is capable of forming an opinion and assessing the information referred to in Article 63(2) MDR to refuse participation in, or to withdraw from, the clinical investigation at any time, is respected by the investigator * patients with renal failure treated or planned to be treated with APD * Body weight ≤ 20 kg * Ability to understand the nature and requirements of the study Exclusion Criteria: * Any conditions which could interfere with the patient's ability to comply with the study * Patient or legal representative is not able to give informed consent according to European Medical Device Regulation and corresponding national regulations * Participation in an interventional clinical study during the preceding 30 days * Previous participation in the same study * Life expectancy \< 3 months * Patients who suffer from peritonitis/exit site infection during the last 4 weeks